Oxford Immunotec
(OXFD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 49,505 | 38,784 | 20,685 | 12,641 |
| Cost of Goods | 24,009 | 18,600 | 12,424 | 8,417 |
| Gross Profit | 25,496 | 20,184 | 8,261 | 4,224 |
| Operating Expenses | 47,366 | 28,135 | 21,616 | 17,965 |
| Operating Income | -21,861 | -7,351 | -12,931 | -13,324 |
| Interest Expense | 0 | 328 | 1,477 | 0 |
| Other Income | -159 | -893 | -626 | 101 |
| Pre-tax Income | -22,020 | -8,572 | -15,034 | -13,223 |
| Income Tax | 154 | 92 | -151 | -119 |
| Net Income Continuous | -22,174 | -8,664 | -14,883 | -13,104 |
| Net Income | $-22,174 | $-8,664 | $-14,883 | $-13,104 |
| EPS Basic Total Ops | -1.28 | -2.26 | -8.44 | -10.78 |
| EPS Basic Continuous Ops | -1.28 | -2.26 | -8.44 | -10.78 |
| EPS Diluted Total Ops | -1.28 | -2.26 | -8.44 | -10.78 |
| EPS Diluted Continuous Ops | -1.28 | -2.26 | -8.44 | -10.78 |
| EPS Diluted Before Non-Recurring Items | -1.28 | N/A | N/A | N/A |
| EBITDA(a) | $-20,119 | $-6,250 | $-12,130 | $-12,694 |